Salmon Surprise: House Opposes FDA Frankenfish Approval

The eminent fisheries writer Paul Greenberg recently gutted and filleted the rationale for a novel type of farmed salmon genetically altered to grow faster. The "improved" fish, created by a Massachusetts-based company called AquaBounty Technologies, threatens to "escape and contaminate wild populations of salmon," Greenberg wrote. And the business model AquaBounty has in mind is ecologically insane: "the fish requires much wasteful transport since it would be cloned in Canada, grown in Panama, and then flown back to the U.S. for consumption." On top of those obvious drawbacks, the GMO salmon literally offers no benefits to the environment or consumers. "It is completely unnecessary," he concludes. Its only rationale is economic -- as defined narrowly by the interests of the AquaBounty shareholders. Greenberg writes:

"It seems to me that what the AquaBounty AquAdvantage salmon represents is the privatization of the salmon genome. Should salmon farming come to be dominated by the AquAdvantage fish, farmers could become dependent on a single company for their stock, just as soy, corn, and wheat farmers must now rely on large multinationals like Monsanto to provide seed for their fields year in and year out. AquaBounty will literally own salmon farming." 

View the Original article

Neotame Receives FDA Approval But is Not Widely Used Yet

By Dr.Mercola

For related articlesand more information, please visit OCA's Food Safety page, and our Millions Against Monsanto page.

Since 2002 an artificial sweetener called neotame has been approved for use in food and drink products around the world, although so far its use appears to be very limited.

Neotame is a chemical derivative of aspartame, and judging by the chemicals used in its manufacturing, it appears even more toxic than aspartame, although the proponents of neotame claim that increased toxicity is not a concern, because less of it is needed to achieve the desired effect.

Neotame is bad science brought to you by the Monsanto Company.

If Monsano truly had nothing to fear with either of these artificial chemical sweeteners, they would have funded rigorous independent testing for safety. To date they have not, and they won't, because virtually every independent analysis of aspartame not conducted by Monsanto partners has revealed a long list of disturbing side effects, mostly neurological in nature.

Monsanto also has now sold the NutraSweet Company to someone else, but the approval of neotame came under Monsanto's ownership, and was most likely a result of Monsanto's cozy relationship with the FDA. More about that in a minute.

View the Original article

GM Food Battle Moves to Fish as Super-Salmon Nears US Approval

Buried in a prospectus inviting investors to buy shares in a fledgling biotech company is an arresting claim attributed to the UN's Food and Agriculture Organization.

"Commercial aquaculture is the most rapidly growing segment of the agricultural industry, accounting for more than $60bn sales in 2003. While land-based agriculture is increasing between 2% to 3% per year, aquaculture has been growing at an average rate of approximately 9% per year since 1970."

And then the prospectus for the US company AquaBounty offers this observation to tantalize prospective investors: "The traditional fishery harvest from the ocean has stagnated since 1990."

So what is to be done to satisfy the world's seemingly insatiable appetite for fish? An appetite that will see the consumption of farmed fish outpace global beef consumption by nearly 10% within five years, according to the UN?

AquaBounty, whose shares are sold on London's Alternative Investment Market, thinks it has the answer. And if, as looks increasingly likely, the US government agrees, the implications for global food production will be enormous. Welcome to the new world heralded by the "GM salmon".

The company's dream of selling genetically modified salmon eggs that allow the fish to grow to maturity in half the normal time received a giant fillip last week when it announced that the US Food and Drug Administration (FDA) was close to granting approval.

A positive FDA response would see salmon become the first GM-engineered animal marketed for human consumption. Dramatically speeding up the time it takes to harvest a mature salmon could stimulate a huge rise in production, making salmon plentiful and cheaper, GM enthusiasts say.


View the Original article